West Pharmaceutical Services, Inc. (WST)
364.98
-0.03
(-0.01%)
USD |
NYSE |
Oct 02, 16:00
364.75
-0.23
(-0.06%)
Pre-Market: 20:00
West Pharmaceutical Services Net Income (Quarterly) : 154.00M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 154.00M |
| March 31, 2026 | 138.80M |
| December 31, 2025 | 132.10M |
| September 30, 2025 | 140.00M |
| June 30, 2025 | 131.80M |
| March 31, 2025 | 89.80M |
| December 31, 2024 | 130.10M |
| September 30, 2024 | 136.00M |
| June 30, 2024 | 111.30M |
| March 31, 2024 | 115.30M |
| December 31, 2023 | 137.00M |
| September 30, 2023 | 161.30M |
| June 30, 2023 | 155.10M |
| March 31, 2023 | 140.00M |
| December 31, 2022 | 103.00M |
| September 30, 2022 | 120.60M |
| June 30, 2022 | 188.50M |
| March 31, 2022 | 173.80M |
| December 31, 2021 | 147.70M |
| September 30, 2021 | 175.60M |
| June 30, 2021 | 187.30M |
| March 31, 2021 | 151.20M |
| December 31, 2020 | 98.40M |
| September 30, 2020 | 82.30M |
| June 30, 2020 | 91.20M |
| Date | Value |
|---|---|
| March 31, 2020 | 74.30M |
| December 31, 2019 | 63.90M |
| September 30, 2019 | 56.30M |
| June 30, 2019 | 66.10M |
| March 31, 2019 | 55.40M |
| December 31, 2018 | 52.00M |
| September 30, 2018 | 55.20M |
| June 30, 2018 | 56.10M |
| March 31, 2018 | 43.60M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 51.00M |
| June 30, 2017 | 38.80M |
| March 31, 2017 | 60.90M |
| December 31, 2016 | 39.10M |
| September 30, 2016 | 37.60M |
| June 30, 2016 | 44.70M |
| March 31, 2016 | 22.10M |
| December 31, 2015 | 33.40M |
| September 30, 2015 | 1.50M |
| June 30, 2015 | 27.80M |
| March 31, 2015 | 32.90M |
| December 31, 2014 | 31.40M |
| September 30, 2014 | 31.00M |
| June 30, 2014 | 37.60M |
| March 31, 2014 | 27.10M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Globus Medical, Inc. | 151.57M |
| Veracyte, Inc. | 25.49M |
| Hinge Health, Inc. | 43.10M |
| The Cooper Cos., Inc. | 432.80M |
| Repligen Corp. | 5.008M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 872.40M |
| Total Expenses (Quarterly) | 718.40M |
| EPS Diluted (Quarterly) | 2.160 |
| Enterprise Value | 25.58B |
| Gross Profit Margin (Quarterly) | 37.83% |
| Profit Margin (Quarterly) | 17.65% |
| Earnings Yield | 2.14% |
| Operating Earnings Yield | 2.77% |
| Normalized Earnings Yield | 2.253 |